SEQUENTIAL HAPLOIDENTICAL-CORD BLOOD HEMATOPOIETIC STEM-CELL TRANSPLANTATION WITH PT-CY/FLU IN PEDIATRIC ACUTE LEUKEMIA
EHA Library, Zhilin Hu, 4208808
COMPARATIVE OUTCOMES OF PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC NEOPLASM (MDS)/MYELOPROLIFERATIVE NEOPLASM (MPN) OVERLAP VERSUS DE NOVO MDS
EHA Library, Alastair Williams, 4208809
SURVIVAL IMPACT AND PREDICTORS OF GRAFT DYSFUNCTION AFTER HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH PTCY: A MEXICAN TERTIARY CENTER EXPERIENCE
EHA Library, Mistral Castellanos-Mares, 4208810
THE POWER OF DONOR AGE: A SINGLE-CENTER ANALYSIS OF SURVIVAL FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Taner Tan, 4208811
IMPACT OF CPE/ESBL ENTEROBACTERALES COLONIZATION AND ANTIBIOTIC DE-ESCALATION ON OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A SINGLE-CENTER STUDY
EHA Library, Roberto Bono, 4208812
INITIAL RESULTS OF POSTTRANSPLANTATION LOW-DOSE INOTUZUMAB OZOGAMICIN TO PREVENT RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, aiming pang, 4208813
CLINICAL OUTCOMES AND SAFETY OF EXTRACORPOREAL PHOTOPHERESIS ALONE OR COMBINED WITH RUXOLITINIB IN CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Library, Christian Koch, 4208815
ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADVANCED CUTANEOUS T-CELL LYMPHOMA: EXPERIENCE WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GVHD PROPHYLAXIS
EHA Library, Seda Cakmak, 4208818
IMPROVED OUTCOMES WITH YOUNGER RELATED HAPLOIDENTICAL DONORS IN PEDIATRIC AML UNDERGOING HAPLO-HSCT
EHA Library, Qingwei Wang, 4208821
HAPLOIDENTICAL TRANSPLANTATION WITH UNRELATED CORD BLOOD SUPPORT (SZ-19-TM PROTOCOL) IMPROVES OUTCOMES IN PEDIATRIC TRANSFUSION-DEPENDENT THALASSEMIA: A LARGE-SCALE RETROSPECTIVE COHORT STUDY
EHA Library, Ruihao Zheng, 4208822
IMPACT OF AGE ON OUTCOME OF VENETOCLAX-BASED CONDITIONING REGIMEN FOR OLDER PATIENTS WITH AML/MDS FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Panpan Zhu, 4208823
MONOCYTE SUBSETS AND MONOCYTE-RELATED CYTOKINES AS POTENTIAL BIOMARKERS IN CHRONIC GRAFT-VERSUS-HOST DISEASE
EHA Library, Antonija Babić, 4208824
EFFECTS OF TWO ANTITHYMOCYTE GLOBULIN CONDITIONING REGIMENS ON IMMUNE RECONSTITUTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Hui Wang, 4208829
AI BASED FLT3-ITD SENSITIVITY PREDICTION AND ITS CORRELATION WITH CLINICAL OUTCOMES IN FLT3-ITD AML PATIENTS RECEIVED ALLOGENEIC HCT +/- FLT3 INHIBITOR MAINTENANCE
EHA Library, Seda Cakmak, 4208830
THE CRL4‑DCAF13 UBIQUITIN E3 LIGASE MAINTAINS RIBOSOME BIOGENESIS AND PROTEIN TRANSLATION IN HEMATOPOIETIC STEM CELLS BY STABILIZING RRS1 THROUGH K27-LINKED NON-DEGRADATIVE UBIQUITINATION.
EHA Library, Mengke Li, 4208831
LEUKEMIC STEM CELLS ORCHESTRATE TGFΒ-DEPENDENT BONE MARROW NICHE REMODELING IN AML XENOGRAFT MODELS
EHA Library, Karin Prummel, 4208832
MONOCYTE AND LYMPHOID LINEAGES BIFURCATE FROM COMMON PRECURSORS DISTINCT FROM NEUTROPHIL LINEAGE DURING HEMATOPOIESIS
EHA Library, Yongjian Yue, 4208833
INFLAMED BONE MARROW STROMAL NICHES DRIVE A HIGH‑ENTROPY INFLAMMATORY‑STEMNESS STATE AND HEMATOPOIETIC STEM CELL DYSFUNCTION IN SICKLE CELL DISEASE
EHA Library, Nadia Carlesso, 4208834
QUIESCENT FETAL, NEONATAL, AND ADULT HUMAN HEMATOPOIETIC STEM CELLS ARE SELECTIVELY MAINTAINED IN FLT3-LIGAND CULTURES
EHA Library, Margarita MacAldaz, 4208837
ALTERED GLUTAMINE METABOLISM IMPAIRS THE HAEMATOPOIETIC STEM CELL RESPONSE TO INFECTION
EHA Library, Charlotte Hellmich, 4208838
LEVERAGING THE INTESTINAL MICROBIOTA TO IMPROVE HSC ENGRAFTMENT
EHA Library, Christopher Peek, 4208842
CLONAL EVOLUTION OF RAS-MAPK MUTATIONS IN HISTIOCYTIC NEOPLASMS REVEALS DISTINCT TRAJECTORIES OF ABERRANT MYELOPOIESIS IN CHILDREN VERSUS ADULTS
EHA Library, Antonia Cuff, 4208843
WNT10B REGULATES THE HEMATOPOIETIC RESPONSE TO ACUTE AND CHRONIC STRESS
EHA Library, Magdalena Havlova, 4208844
SKP2-INHIBITION IN HUMAN HSPCS: A NEW PROMISING STRATEGY TO ENHANCE HSC MAINTENANCE AND STRESS TOLERANCE DURING IN-VITRO MANIPULATION
EHA Library, Federica Di Biase, 4208846
BONE MARROW MESENCHYMAL CELLS UNDERGO INFLAMMATORY MYOFIBROBLAST DIFFERENTIATION UPON ALLOGENEIC HSCT CORRELATING WITH AN ALTERED SUPPORT OF HEMATOPOIESIS
EHA Library, Sara Garaali, 4208848
DECODING BLOOD FORMATION: LINKING CODON USAGE, TRANSFER RNA EXPRESSION AND CELL IDENTITY IN HEMATOPOIESIS
EHA Library, Marius Külp, 4208849
IRON DEFICIENCY IS ASSOCIATED WITH REDUCED TRANSFERRIN RECEPTOR 2 EXPRESSION IN EARLY HEMATOPOIETIC PROGENITORS
EHA Library, João Vitor Facco, 4208851
SCRNA-SEQ ANALYSIS WORKFLOW TO CHARACTERIZE WNT-MODULATED MESODERM AND HEMATOPOIETIC TRAJECTORIES IN HUMAN GASTRULOIDS
EHA Library, Elin Hilpold-Berntsson, 4208852
THE EFFECT OF STATIN THERAPY AND SMALL DENSE LIPOPROTEINS ON CLONAL HAEMATOPOIESIS OF INDETERMINATE POTENTIAL: A TWO SAMPLE MENDELIAN RANDOMISATION STUDY.
EHA Library, Ellen Nuttall Musson, 4208853
SELECTIVE PRESERVATION OF FYN SIGNALING BY PONATINIB ENHANCES CAR-T CELL PERSISTENCE AND FUNCTIONAL DURABILITY IN B-ALL
EHA Library, Xin Li, 4208858
LONG-TERM SAFETY OF CAR T-CELL THERAPY WITH LISOCABTAGENE MARALEUCEL AND IDECABTAGENE VICLEUCEL: ANALYSIS OF SECOND PRIMARY MALIGNANCY (SPM) AND VECTOR-ASSOCIATED OUTCOMES
EHA Library, Matthew Lunning, 4208860
CD1C-RESTRICTED TCR COMBINED WITH CD38-CCR ENABLES POTENT DUAL-TARGETING IMMUNOTHERAPY IN ACUTE LEUKEMIA
EHA Library, Ivan Civettini, 4208861
CORD BLOOD-DERIVED NK CELLS ENGINEERED WITH  A NOVEL HIGH-AFFINITY CAR RECOGNIZING CLL-1 EXHIBIT SIGNIFICANT ANTI-LEUKEMIA EFFECTS IN VIVO
EHA Library, Makiko Suga, 4208863
GAMMA DELTA T‑CELL THERAPY NAKU OUTPERFORMS AND ENHANCES AZA/VEN TREATMENT IN PATIENT-DERIVED EX VIVO AML MODELS
EHA Library, Mika Kontro, 4208866
DUAL-INPUT LOGIC-GATED CAR NK CIRCUITS HARNESSING IMMUNE SYNAPSE PROTEASE ACTIVITY FOR TUMOR CONFINED MULTI ANTIGEN ENGAGER CASCADES
EHA Library, Didem Cakirsoy Akyoney, 4208868
BIOLOGICAL PROPERTIES AND CLONALITY OF ENGINEERED HEMATOPOIETIC STEM/PROGENITOR CELLS PERSISTING LONG-TERM AFTER GENE THERAPY
EHA Library, Serena Scala, 4208869
FROM BENCH TO BODY: STABLE IN VIVO CAR T-CELL ENGINEERING WITH A T CELL–TROPIC AAV–TRANSPOSON PLATFORM
EHA Library, Mobina Ostadiasrami, 4208872
EARLY IGFBP6 DOWNREGULATION AND ROCK2 ACTIVATION IDENTIFY PATIENTS AT RISK OF ICANS AFTER CD19 CAR-T THERAPY: A REAL-WORLD MOLECULAR MONITORING STUDY
EHA Library, Sara Galimberti, 4208873
SINGLE-CELL PROFILING REVEALS DIFFERENTIAL ACTIVATION OF EX VIVO EXPANDED NATURAL KILLER CELLS ACROSS PEDIATRIC LEUKEMIA SUBTYPES
EHA Library, Tiina Tuononen, 4208876
CAR-T CELL THERAPY FOR THE TREATMENT OF A HIGH-RISK PEDIATRIC AMKL: PRECLINICAL RESULTS
EHA Library, Marta Tassoni, 4208877
CTD402 ALLOGENEIC ANTI-CD7 CAR T-CELL THERAPY IS SAFE AND EFFECTIVE IN ADOLESCENT/PEDIATRIC PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) T-ALL/LBL
EHA Library, Xian Zhang, 4208882
LONG-TERM FOLLOW-UP CONFIRMS DURABLE CLINICAL BENEFITS OF EXAGAMGLOGENE AUTOTEMCEL IN TRANSFUSION-DEPENDENT B-THALASSEMIA: FINAL RESULTS OF THE CLIMB THAL-111 STUDY
EHA Library, Roland Meisel, 4208884
PD-1AB21-EXPRESSING, ANTI-CD19 CAR T CELLS FOR PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: AN OPEN-LABEL, SINGLE-ARM, PHASE 1 STUDY
EHA Library, Bo Peng, 4208886
SECONDARY MALIGNANCIES AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY: A REPORT FROM THE EBMT REGISTRY ON 509 CASES.
EHA Library, Annalisa Ruggeri, 4208888
PAIRED SINGLE-CELL ANALYSIS OF STARTING MATERIAL AND CAR T PRODUCT IDENTIFIES CD8+ TEMRA SENESCENCE PROGRAMS LINKED TO CLINICAL RESPONSE IN DLBCL
EHA Library, Yue Chun, 4208889
SEVERE DELAYED NON-ICANS NEUROTOXICITY AFTER BCMA-DIRECTED CAR-T CELLS IN MULTIPLE MYELOMA: REAL-WORLD OUTCOMES AND IMPLICATIONS FOR STRUCTURED NEUROLOGY–ONCOLOGY CARE
EHA Library, Tim Richardson, 4208891
THE SUCCESS OF CAR T-CELL THERAPY IS DETERMINED BY PRE-INFUSION DISEASE CONTROL AND POST-INFUSION MRD CLEARANCE MEASURED BY CTDNA IN PATIENTS WITH B-CELL LYMPHOMA
EHA Library, Tim Versteegen, 4208894
TAZEMETOSTAT-MEDIATED IMMUNE REMODELING IN B-CELL LYMPHOMAS RECEIVING CART
EHA Library, Samuel Yamshon, 4208895
DURABLE CLINICAL BENEFITS WITH EXAGAMGLOGENE AUTOTEMCEL FOR PEDIATRIC PATIENTS (5-11 YEARS) WITH TRANSFUSION-DEPENDENT Β‑THALASSEMIA AND SICKLE CELL DISEASE WITH RECURRENT VASO-OCCLUSIVE CRISES
EHA Library, Franco Locatelli, 4208896
REAL-WORLD USE OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) FOR SEVERE THROMBOCYTOPENIA AFTER CAR T-CELL THERAPY: PLATELET RECOVERY AND TRANSFUSION BURDEN STRATIFIED BY CAR-HEMATOTOX
EHA Library, Zixun Yan, 4208898
TIME FROM CAR-T EVALUATION TO LEUKAPHERESIS IN B-CELL MALIGNANCIES: ASSOCIATION WITH INFUSION RATES AND OUTCOMES
EHA Library, Justin Desroches, 4208900
COMPARATIVE EFFICACY AND SAFETY OF BCMA-TARGETED VERSUS GPRC5D-TARGETED CAR-T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS
EHA Library, Yanling Li, 4208902
EARLY HYPERFILTRATION PREDICTS SUBSEQUENT RENAL DECLINE IN SICKLE CELL DISEASE: A LONGITUDINAL TRAJECTORY STUDY
EHA Library, Laura Corona, 4208910
THE HIDDEN BURDEN: FEMALE SEXUAL DYSFUNCTION AND PAIN CRISES IN SICKLE CELL DISEASE
EHA Library, Fernanda Bacarin, 4208912
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDHOOD B-ALL WITH TCF3::PBX1: A RETROSPECTIVE ANALYSIS OF 70 PATIENTS FROM A SINGLE CENTER
EHA Library, YUN WANG, 4208816
OUTCOMES OF MYELOFIBROSIS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION WITH TACROLIMUS/METHOTREXATE/RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS
EHA Library, Sandro Pino-Ascencio, 4208817
YOUNG PATIENTS WITH STANDARD-RISK MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION ARE EXPECTED TO ACHIEVE FUNCTIONAL CURE:A REAL-WORLD MULTICENTER ANALYSIS
EHA Library, Li Bao, 4208819
A MULTICENTER CLINICAL STUDY COMPARING HETROMBOPAG AND ELTROMBOPAG FOR PLATELET ENGRAFTMENT AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Aoxue Tan, 4208820
DOES THE AGE-ADJUSTED HCT-CI RETAIN PROGNOSTIC SIGNIFICANCE IN HAPLOIDENTICAL TRANSPLANTATION WITH PTCY?
EHA Library, Hakan Goker, 4208825
UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS: ELEVATING EARLY EFFICACY IN GASTROINTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Fang Zhou, 4208826
PSYCHIATRIC STATUS IN CHRONIC GRAFT-VERSUS-HOST DISEASE: A REAL-WORLD DATA.
EHA Library, Jan Puchowski, 4208827
ABSOLUTE AND RELATIVE CD34+ COUNTS AS PREDICTORS OF MOBILIZATION SUCCESS: EXPERIENCE FROM A BRAZILIAN ONCOLOGY CENTER
EHA Library, Marcos Henrique Fogale Piccoli Silva, 4208828
IMPAIRED INTERFERON RESPONSE IN BRAFV600E MYELOID PROGENITORS OF LANGERHANS CELL HISTIOCYTOSIS
EHA Library, Maki Sakuma, 4208835
CHROMATIN ACCESSIBILITY ENCODES LINEAGE PLASTICITY IN FIRST-TRIMESTER FETAL HEMATOPOIETIC STEM AND PROGENITOR CELLS
EHA Library, Sara Palo, 4208836
MULTIMODAL OMICS IDENTIFY AN AGE RESILIENT MULTIPOTENT PROGENITOR POPULATION IN THE HEMATOPOIETIC SYSTEM
EHA Library, Mari Carmen Romero-Mulero, 4208839
CHARACTERIZATION OF THE BONE MARROW NICHE INTERACTOME OF CHEMORESISTANT ACUTE MYELOID LEUKEMIA
EHA Library, Maria Pereira, 4208840
ABNORMALITIES IN THE BONE MARROW NICHE ARE SUSTAINED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION, SUPPORTING CONTINUED LEUKEMIC DYNAMICS AND RELAPSE OF ACUTE MYELOID LEUKEMIA
EHA Library, Shlomit Yehudai-Reshef, 4208841
DEVELOPMENT OF A TRACTABLE EX VIVO MODEL OF HAEMATOPOIESIS ENABLES CRISPR SCREENING OF LINEAGE REGULATORS
EHA Library, Elizabeth Brown, 4208845
DIVERGENT EFFECTS OF TET2- AND DNMT3A-MUTANT CLONAL HEMATOPOIESIS ON BREAST CANCER PROGRESSION UPON AGING
EHA Library, Nagihan Gizay Gönüllü, 4208847
UNCOVERING NEW ROLES FOR H/ACA SNORNPS IN MYC-DRIVEN ONCOGENIC STRESS AND HEMATOPOIESIS
EHA Library, Silvia Tucciarone, 4208850
A STANDARDIZED IN VITRO BONE NICHE MODEL FOR QUANTITATIVE ANALYSIS OF OSTEOCLAST-MEDIATED MICROENVIRONMENT REMODELING RELEVANT TO HEMATOLOGIC MALIGNANCIES
EHA Library, Min Wu, 4208854
FLT3 INHIBITION SYNERGIZES WITH DNA DAMAGING AGENTS TO ELIMINATE HEMATOPOIETIC STEM AND PROGENITOR CELLS BY SUPPRESSING DNA REPAIR PATHWAYS
EHA Library, Samuel Taylor, 4208855
P-TERT RELATED ADAPTIVE SOMATIC HEMATOPOIETIC MOSAICISM IN PATIENTS WITH TELOMERE BIOLOGY DISORDERS
EHA Library, Madeline Franke, 4208856
PRECLINICAL CHARACTERIZATION OF EVX-04, AN AI-DESIGNED OFF-THE-SHELF CANCER VACCINE TARGETING ENDOGENOUS RETROVIRAL ANTIGENS IN ACUTE MYELOID LEUKEMIA
EHA Library, Søren Vester Kofoed, 4208857
CO-RECEPTOR ATTENUATION DEFINES A CONVERGENT TRANSCRIPTIONAL STATE OF LONG-TERM PERSISTING CAR-T CELLS DRIVEN BY INTERMITTENT ANTIGEN STIMULATION
EHA Library, Neel Nabar, 4208859
AN IN VIVO EPIGENOME EDITING PLATFORM FOR Β-HEMOGLOBINOPATHIES USING ADENOVIRAL VECTORS
EHA Library, Kiriaki Paschoudi, 4208862
PRE-INFUSION IMMUNE SIGNATURES PREDICT SEVERE CYTOPENIA AFTER CAR T-CELL THERAPY: HIGH-DIMENSIONAL LONGITUDINAL PROFILING IN B-CELL MALIGNANCIES
EHA Library, Julian Liebaert, 4208864
TARGETING TNFΑ AND IFNG REVERSES CAR-T SECRETOME–INDUCED HUMAN HEMATOPOIETIC STEM CELL IMPAIRMENT
EHA Library, Michael Milyavsky, 4208865
ADJUSTABLE TUNING OF CHIMERIC PROTEIN-EXPRESSING T CELLS WITH BSABS TO AUGMENT T-CELL REDIRECTION THERAPY FOR HEMATOLOGICAL MALIGNANCIES.
EHA Library, Junichi Kato, 4208867
INCORPORATING IN VITRO TRANSCRIPTION MRNA TO PROLONG THE HALF-LIFE OF BISPECIFIC ANTIBODY
EHA Library, Yu Yang, 4208870
SCREENING AND VALIDATION OF TCR–PEPTIDE INTERACTIONS USING INTEGRATED BULK AND SINGLE‑CELL IMMUNE RECEPTOR SEQUENCING
EHA Library, Alex Chenchik, 4208871
CD4/CD8 BALANCE IN CIRCULATING CAR T-CELLS SHOWS BIPHASIC PROGNOSTIC IMPACT ON OVERALL SURVIVAL IN LARGE B-CELL LYMPHOMAS
EHA Library, Ludovic Gabellier, 4208874
A TOOLBOX TO VISUALIZE AND QUANTIFY CHIMERIC ANTIGEN RECEPTORS USING SUPERRESOLUTION MICROSCOPY
EHA Library, Thomas Nerreter, 4208875
EXPLORING THE THERAPEUTIC POTENTIAL OF TCR GENE THERAPY WITH ARGINASE 1-TARGETED METABOLIC INTERVENTION IN PRECLINICAL TUMOR MODEL
EHA Library, Anita Kansy, 4208878
ALLOGENEIC BCMA‑TARGETED CAR‑INKT CELLS WITH PD‑1 DISRUPTION EXHIBIT ENHANCED ANTITUMOR POTENCY IN A MULTIPLE MYELOMA PRECLINICAL MODEL
EHA Library, Hua Zhang, 4208879
EFFICACY AND SAFETY OF COMMERCIAL CD19 CAR-T (INATICABTAGENE AUTOLEUCEL) IN RELAPSED/REFRACTORY EXTRAMEDULLARY B-ALL: A LARGE MULTICENTER REAL-WORLD STUDY
EHA Library, Suning Chen, 4208881
RISTOGLOGENE AUTOGETEMCEL TREATMENT RESTORED RED BLOOD CELL HEALTH AND FUNCTION IN PATIENTS WITH SICKLE CELL DISEASE, WITH SICKLING AND RHEOLOGY PARAMETERS COMPARABLE TO SICKLE CELL TRAIT
EHA Library, Priya S. Chockalingam, 4208883
SAFETY AND EFFICACY OF HCD1A-CAR T (OC-1) THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA/LYMPHOMA (T-ALL/LL): A PRE-SPECIFIED INTERIM ANALYSIS.
EHA Library, Nuria Martinez-Cibrian, 4208885
EFFICACY AND SAFETY OF CD19 CAR-T INATICABTAGENE AUTOLEUCEL IN OLDER ADULTS WITH B-ALL IN FIRST COMPLETE REMISSION: A MULTICENTER REAL-WORLD STUDY FROM CHINA
EHA Library, Jin WANG, 4208892
MAINTENANCE THERAPY WITH PD-1 INHIBITOR AND SELINEXOR FOLLOWING CD19/CD22 BISPECIFIC CAR-T CELL THERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE ANALYSIS
EHA Library, Liang Wang, 4208893
CAR T-CELL THERAPY FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE, A REAL-WORLD ANALYSIS ON BEHALF OF THE EBMT LYMPHOMA WORKING PARTY
EHA Library, Fabio Andreozzi, 4208897
RELEVANT STUDY BETWEEN CYTOKINE LEVEL OF PATIENTS TREATED WITH CD7 CAR-T THERAPY AND GVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Dongchu Wang, 4208899
TENACITY-01 A GLOBAL STUDY OF CTD402, ALLOGENEIC ANTI-CD7 CAR T-CELL, IN RELAPSED OR REFRACTORY (R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)
EHA Library, Lori Muffly, 4208901
LATER CAR‑T INFUSIONS INCREASE CYTOKINE RELEASE SYNDROME (CRS): EVIDENCE FOR CIRCADIAN MODULATION OF IMMUNOTHERAPY-RELATED TOXICITY
EHA Library, Danielle DeCicco, 4208903
REAL WORLD EVALUATION OF ENTEROCOLITIS IN CILTA-CEL TREATED PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
EHA Library, Doris Hansen, 4208904
IMMUNE EFFECTOR CELL–ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FOLLOWING CAR T-CELL THERAPY: RESULTS OF A SINGLE-CENTER REAL-WORLD ANALYSIS
EHA Library, Inna Shaforostova, 4208905
INTERNATIONAL EXPERT CONSENSUS ON THE USE OF IMMUNOGLOBULIN REPLACEMENT THERAPY FOR SECONDARY IMMUNODEFICIENCY: A MODIFIED DELPHI STUDY
EHA Library, Michel Delforge, 4208906
OSIVELOTOR IMPROVES BIOMARKERS OF HEMOLYSIS, OXIDATIVE STRESS, AND INFLAMMATION IN PATIENTS WITH SICKLE CELL DISEASE IN A MULTICENTER PHASE 2/3 TRIAL
EHA Library, Santosh Saraf, 4208908
BIOLOGICAL DRIVERS AND FUNCTIONAL IMPACT OF MITOCHONDRIA-RETAINING RED BLOOD CELLS IN SICKLE CELL DISEASE
EHA Library, Alkmini Anastasiadi, 4208909
SICKLE CELL DISEASE IN GERMANY - TRENDS IN EPIDEMIOLOGY, HEALTHCARE UTILIZATION AND DISEASE BURDEN FROM 2015 TO 2024: A CLAIMS DATA ANALYSIS
EHA Library, Nils Schulze, 4208911

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings